Tag: Impulsivity

According to the FDA, healthcare providers should monitor patients on antidepressants like Wellbutrin for emergent symptoms such as impulsivity, especially at the beginning of treatment or with dose changes. While the effects on impulse control vary greatly among individuals, it is a risk factor that requires careful consideration when evaluating if **Can Wellbutrin increase impulsivity?**.

According to the FDA, certain adverse behavioral events, including impulsivity, have been reported in patients treated with antidepressants. But can antidepressants cause impulsive behavior directly? This is a concern for patients and clinicians alike, particularly regarding initial treatment phases or dose changes.

According to a 2022 study in *ScienceDirect*, drugs that increase dopamine signaling are disproportionally more frequently reported as causing impulse control disorders. This guide explains **what medication can cause impulsive behavior** and highlights the drug classes most commonly implicated, such as dopamine agonists, psychostimulants, and some antipsychotics.

Intuniv, the extended-release form of guanfacine, is an FDA-approved non-stimulant medication for attention deficit hyperactivity disorder (ADHD) in children and adolescents, though it is also commonly used off-label for adults. It offers an effective alternative or adjunct therapy for those who do not tolerate or respond well to traditional stimulant medications.

Kapvay (clonidine extended-release) was FDA-approved in 2009 for the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents, and can be used alone or with other stimulants. The medication works differently than traditional stimulants and offers a targeted approach to managing core ADHD symptoms.